Search

Found 373 Results
Page 1 of 38

Onxeo publishes Letter to Shareholders and provides update on its developments


Paris (France), February 2, 2021 – 9 pm CET – Onxeo S.A. (Euronext Growth: ALONX; Nasdaq First North: ONXEO), a […]

02/02/2021


ESMO Targeted Anticancer Therapies Congress 2021


  Watch the e-poster “AsiDNA™ targets drug-tolerant persister cells responsible of resistance to PARP inhibitors”  

02/01/2021


H.C. Wainwright Global Life Sciences Conference


  For more information and to register …  


Onxeo Obtains Non-Dilutive Financing of 5 Million Euros in the Form of State Guaranteed Loans


This financing extends the Company’s cash horizon to the 3rd quarter of 2022   Paris (France), January 28, 2021 – […]

01/28/2021


Onxeo to Attend Key Investor and Scientific Conferences


Paris (France), January 11, 2021 – 7:00 am CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

01/11/2021


BioMed Event 2021


  For more information, click here Download the management presentation

01/08/2021



Edison Open House Global Healthcare 2021


  For more information, visit the Edison Open House Global Healthcare 2021 webpage Download the management presentation Access the interview […]


Onxeo Announces its Financial Agenda for 2021


Paris (France), January 7, 2021 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or “the […]

01/07/2021


Page 1 of 38

No more results